Search

Select your region

FCA: Travel insurance signposting rules for consumers with medical conditions – review

11 Apr 2024 (UPDATED: 13 Mar 2026) United Kingdom 1 min read

Following rules introduced by PS20/3, FCA has now published this post-implementation review which looks at firms’ implementation of and compliance with the rules and indicators of the impact of the regulator’s intervention.  FCA considers that the signposting intervention has had a positive, albeit lower than expected, impact on the market.  FCA intends to consult later this year on updating the £100 medical condition premium trigger point for signposting.


Back to top Back to top
You will now find all Law-Now content on CMS.law